Singapore Markets open in 2 hrs 39 mins

Medexus Pharmaceuticals Inc. (MEDXF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.9905-0.0195 (-1.93%)
At close: 03:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.63
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 32.5600
52-week low 30.5850
50-day moving average 31.3280
200-day moving average 31.4475

Share statistics

Avg vol (3-month) 315.34k
Avg vol (10-day) 36.05k
Shares outstanding 520M
Implied shares outstanding 6N/A
Float 817.9M
% held by insiders 111.50%
% held by institutions 10.38%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 318 Dec 2018
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Mar 2022
Most-recent quarter (mrq)30 Dec 2022


Profit margin -10.95%
Operating margin (ttm)4.98%

Management effectiveness

Return on assets (ttm)2.18%
Return on equity (ttm)-56.63%

Income statement

Revenue (ttm)99.73M
Revenue per share (ttm)5.01
Quarterly revenue growth (yoy)35.10%
Gross profit (ttm)43.67M
Net income avi to common (ttm)-10.92M
Diluted EPS (ttm)-1.1230
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)9.27M
Total cash per share (mrq)0.46
Total debt (mrq)65.66M
Total debt/equity (mrq)425.60
Current ratio (mrq)0.61
Book value per share (mrq)1.23

Cash flow statement

Operating cash flow (ttm)-1.52M
Levered free cash flow (ttm)-7.86M